Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Kelly

Showing results (11-20 of 253) with videos related to

Pageof 26
Sort By:
Seminars in Oncology|October 23, 2003
The development of differentiation agents for the treatment of prostate cancerMatt Galsky, W Kevin Kelly
Urology|January 30, 2004
Use of nomograms for predicting survival in patients with castrate prostate cancerMatt Galsky, William Kevin Kelly
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
High-risk localized prostate cancer: a case for early chemotherapyMartin Gleave, W Kevin Kelly
Cancer Journal (Sudbury, Mass.)|April 28, 2007
Histone deacetylase inhibitors: biology and mechanism of actionJanice M Mehnert, Wm Kevin Kelly
Nature Clinical Practice. Oncology|December 3, 2008
Epothilones: tubulin polymerization as a novel target for prostate cancer therapyJames J Lee, W Kevin Kelly
The Lancet. Oncology|December 3, 2014
Effect of docetaxel on safety and efficacy of radium-223Robert B Den, W Kevin Kelly
Applied Ergonomics|August 14, 2017
Controlling robots in the home: Factors that affect the performance of novice robot operatorsConor McGinn, Aran Sena, Kevin Kelly
The Canadian Journal of Urology|April 30, 2014
Practical guide to the use of enzalutamideJean Hoffman-Censits, Wm Kevin Kelly
Oncology (Williston Park, N.Y.)|January 12, 2019
Counterpoint-Prostate Cancer Genomic Analysis: Routine or Research Only?W Kevin Kelly, Karen E Knudsen
British Journal of Haematology|March 8, 2008
Bortezomib-induced reversible posterior leucoencephalopathy syndromeKevin Kelly, Roshni Kalachand, Philip Murphy
Pageof 26

Showing results (11-20 of 253) with videos related to

Sort By:
Pageof 26
Seminars in Oncology|October 23, 2003
The development of differentiation agents for the treatment of prostate cancerMatt Galsky, W Kevin Kelly
Urology|January 30, 2004
Use of nomograms for predicting survival in patients with castrate prostate cancerMatt Galsky, William Kevin Kelly
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
High-risk localized prostate cancer: a case for early chemotherapyMartin Gleave, W Kevin Kelly
Cancer Journal (Sudbury, Mass.)|April 28, 2007
Histone deacetylase inhibitors: biology and mechanism of actionJanice M Mehnert, Wm Kevin Kelly
Nature Clinical Practice. Oncology|December 3, 2008
Epothilones: tubulin polymerization as a novel target for prostate cancer therapyJames J Lee, W Kevin Kelly
The Lancet. Oncology|December 3, 2014
Effect of docetaxel on safety and efficacy of radium-223Robert B Den, W Kevin Kelly
Applied Ergonomics|August 14, 2017
Controlling robots in the home: Factors that affect the performance of novice robot operatorsConor McGinn, Aran Sena, Kevin Kelly
The Canadian Journal of Urology|April 30, 2014
Practical guide to the use of enzalutamideJean Hoffman-Censits, Wm Kevin Kelly
Oncology (Williston Park, N.Y.)|January 12, 2019
Counterpoint-Prostate Cancer Genomic Analysis: Routine or Research Only?W Kevin Kelly, Karen E Knudsen
British Journal of Haematology|March 8, 2008
Bortezomib-induced reversible posterior leucoencephalopathy syndromeKevin Kelly, Roshni Kalachand, Philip Murphy
Pageof 26